HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the article, please login or register as reader.

2021

Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 5 - 17)

Impact of Health Education on the Treatment of Hepatitis C Infection in Patients in Drug Addiction Treatment Centres in Serbia

Jovanovic M., Todorov N., Dickov A., Arsenijevic V., Kovacevic M., Mijailovic Z., and Colovic S.

Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 19 - 23)

Subjective Opiate Withdrawal Scale and Toxicological Screening in Malaysian Opioid Drug Addicts

Wiraagni I.A., Mohd M.A., Rashid R.b.A., and Haron D.E.b.M.

Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 25 - 31)

Self Efficacy and Quality of Life of Participants Undergoing Treatment for Drug Addiction in Pakistan

Ishrat S., Naz S., Gul I., and Sireer N.

Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 33 - 46)

Opioid Agonist Treatment for Opioid Use Disorder Patients in Central Asia

Michels I.I., Stöver H., Aizberg O., and Boltaev A.

Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 47 - 55)

A Shared Medical Appointment (Sma) Model for U.S. Veterans Treated with Buprenorphine in an Outpatient Setting: an Appraisal of Mortality, Risk, and Protective Factors

Phelan J.E.

Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 57 - 60)

Risk of Sleep Disordered Breathing and Treatment Dilemma While on Methadone Maintenance Treatment in Opioid Use Disorder Patients

Riaz U.

Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 61 - 64)

The ‘Prison Zero Hepatitits' Project in France: A New Pathway for Hcv Microelimination

Remy A.-J., Roy B., and Hervet J.

Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 65 - 70)

Switching All Patients from Racemic to Levomethadone as a Challenge to Public Health

Deruvo G., Elia C., Mercadante M., Mongiello F., Guareschi M., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 71 - 79)

Psychopathological Syndromes and Risk of Alcoholism in Heroin Use Disorder Patients Compared with Substance Non-User Peers

Miccoli M., Della Rocca F., Maremmani A.G.I., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 79 - 80)

The Complexities of Monitoring and Responding to Illegal Ghb Use and Overdose - Are We Sufficiently Equipped?

Crowley D., and Van Hout M.C.

Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 5 - 11)

Outcomes for Patients Receiving Telemedicine-Delivered Medication-Based Treatment for Opioid Use Disorder: A Retrospective Chart Review

Weintraub E., Greenblatt A.D., Chang J., Welsh C.J., Berthiaume A.P., Goodwin S.R., Arnold R., Himelhoch S.S., Bennett M.E., and Belcher A.M.

Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 13 - 27)

Effectiveness of Medication-Assisted Therapy in Malaysia. A Systematic Review and Meta-Analysis after a Decade.

Musa R., and Yee A.

Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 29 - 47)

Agonist Opioid Treatment for Opioid Dependents in Germany 2019

Stöver H., Michels I.I., and Gerlach R.

Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 49 - 57)

How to Improve a Poorly Running Agonist Opioid Treatment (Aot). Part 7: Overcoming the Alcohol Dependence of Methadone Patients

Ulmer A., Frietsch B., and Mueller M.

Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 59 - 63)

Obsessive Compulsive Disorder among Patients Enrolled in Methadone Maintenance Therapy

Kheradmand A., Khalatabadi P., and Seif P.

Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 65 - 68)

Rehabilitation of Patients Dependent on New Psychoactive Substances in Russian Federation

Kekelidze Z.I., Kozlov A.A., Klimenko T.V., Igumnov S.A., and Shakhova S.M.

Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 69 - 77)

Further Evidence of a Psychopathology Specific to Substance Use Disorder. Relationships between Psychopathological Dimensions and Alcohol Craving in Recreational Drinkers

Miccoli M., Poli A., Pagni L., Conversano C., Pani P.P., Maremmani A.G.I., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 79 - 80)

Effectiveness of Deep Brain Stimulation in Treatment of Severe Addiction

Famitafreshi H., and Karimian M.

Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 5 - 11)

Drugs as communication between ego and self. Revisiting C.G. Jung

Leoncini T., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 13 - 21)

The relationship of alexithymia with difficulty in emotional regulation, anxiety, and depression symptoms in a group of patients receiving opioid maintenance treatment

Karabulut V., Evren C., Alniak İ., Helin Carkcı O., and Yilmaz Cengel H.

Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 23 - 27)

Follow-up of serum naltrexone levels after naltrexone implant in opioid use disorder

Kulaksızoğlu B., Erdoğan A., Cinemre B., Topcuoğlu M., Coşkun M.N., Özdemir M., Bingöl M.S., and Kuloğlu M.M.

Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 29 - 36)

Somatic diseases in patients with opioid use disorder

Simonovska N., Velik-Stefanovska V., Babulovska A., Pereska Z., Kostadinoski K., and Naumoski K.

Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 37 - 44)

Patterns of pain killers and other opioid use in patients admitted to a detoxification and dual diagnosis unit, 2016-19: a retrospective cohort study

Casado-Espada N.M., Alvarez-Navares A., Lozano-Lopez M.T., Gamonal-Limcaoco R.S., de la Iglesia-Larrad J., Garzón M.Á., Dening T., and Roncero C.

Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 45 - 50)

Take-home naloxone carriage among opioid users in Lanarkshire

Hill D.R., Al Azizi B., Conroy S., and Akram G.

Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 51 - 53)

How supportive and understandable are health care practitioners toward people who use drugs in Albania?

Tivari Bitri S., Puca E., Thoma E., and Sotiri E.

Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 55 - 60)

Covid-19 and addiction: A comparison between Substance Use Disorder patients and gamblers

Incerti C.C., Carenti M.L., Catalano G., De Luca O., Arcangeli N., Manasse D., and Casella P.

Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 61 - 74)

Exploring the Depressive Syndrome of Heroin Use Disorder patients. Relationships between Worthlessness/Being Trapped, Deficit Reward and Post-Withdrawal Syndromes

Della Rocca F., Novi M., Maremmani A.G.I., Pani P.P., Miccoli M., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 77 - 81)

Caring for opioid drug users during the COVID-19 pandemic – a commentary on the Irish experience

Crowley D., and Cullen W.

Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 81 - 85)

Despite Repeated Criticism, Medications (Methadone, Suboxone) For Opioid Use Disorder Continue Being Called "Substitution" Treatments

Appel P.

Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 5 - 14)

The effect of cognitive behaviour group therapy on drug dependence among heroin addicts in Taiwan: What roles do drug beliefs, drug craving, and intention to relapse play?

Lin M.-F., and Lang S.-Y.

Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 15 - 23)

Effect of methadone and treadmill exercise on myocardial infarction in morphine withdrawn rats

Alizadeh M., Miladi-Gorji H., Sameni H., Bandegi A., Ebadatipour E., and Zahedi-Khorasani M.

Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 25 - 32)

Traditional Chinese Medicine-Based Medication-Assisted Therapy for Switching from Methadone to Buprenorphine/Naloxone in treating Opioid Use Disorder

Yu K.-C., Wei H.-T., Chih S.-Z., and Hsu C.-H.

Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 33 - 41)

Effectiveness, tolerability and safety of a long-term therapy with levomethadone in clinical practice: a retrospective observational study

Consoli A.

Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 43 - 50)

Naltrexone Implant Use in Opioid Use Disorder; an example from Turkey

Demir B., and Altindag A.

Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 51 - 58)

An Assertive Outreach Intervention for Treatment of Opioid Use Disorder in Young Adults

Wenzel K., Fishman M., Wildberger J., Vo H., and Burgower R.

Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 59 - 68)

Methadone intoxications and methadone-related deaths during a five-year period in Vojvodina, Serbia

Nosek I.P., Dušan, Mijatović Jovin V., Samojlik I., Petković S.D., Zorka Knezovic, Vladimir, and Dickov A.

Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 69 - 79)

Early-readmission after Agonist Opioid Treatment in five European countries. A drug addiction health policy challenge?

Maremmani I., Hill D., Scherbaum N., Auriacombe M., Bacciardi S., Benyamina A., Casella P., D'Agnone O., Daulouede J.-P., Deruvo G., Fonseca F., Guareschi M., Maremmani A.G.I., Villeger P., Ratcliffe K., Somaini L., Touzeau D., Vernole E., Walcher S., and

Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 5 - 14)

Comparison of Impulsivity with Self-Report and Behavioral Method in Patients with Opioid Use Disorder

Barlas L., Ünübol B., and Dağ İ.

Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 15 - 22)

Reducing Opioid Dependence Therapy risk in the prison system and the use of extended-release buprenorphine as an additional treatment option: a consensus statement

Gross G., Conroy S., Leonardi C., Meroueh F., Antolin J.M., and Somaini L.

Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 25 - 36)

RBP-6000: a rationally designed prolonged-release buprenorphine formulation

Wiest K., Shaya G., Somaini L., and Greenwald M.

Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 37 - 45)

A qualitative study of physical activity and dietary practices of people accessing opioid agonist treatment in Ireland

Matthews E., Van Hout M.C., Scheibein F., and Cowman M.

Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 47 - 56)

Berberis integerrima and berberine attenuate morphine reward memory and restore the reduction of CSF serotonin levels following morphine conditioned place preference in rats

Sabeghi S., Zahedi-Khorasani M., Ghanbari A., Khaleghian A., Doroodi F., and Miladi-Gorji H.

Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 57 - 66)

Microdosing Case Study Series – Transferring from Methadone to Oral Buprenorphine

Cassells N., Hill D.R., Marr E., and Stewart E.

Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 67 - 73)

What makes a co-dependent partner? - A linear regression model

Knapek É., Balázs K., and Kuritárné Szabó I.

Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 75 - 80)

Convergent validity of five-dimension psychopathology of Addiction: relationships with aggressive behaviour

Maremmani A.G.I., Della Rocca F., Bacciardi S., Miccoli M., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 5 - 11)

Involuntary Commitment for Opioid Use Disorders: Is There Any Predictor of Recommitments?

Ak S., and Arikan R.

Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 13 - 24)

The neurophysiological correlates of cognitive functions during methadone and buprenorphine maintenance treatment: The erp study

Markovska-Simoska S., Ignjatova L., Kiteva-Trenchevska G., and Pop-Jordanova N.

Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 25 - 32)

Levels of leptin and adiponectin after initiation of methadone maintenance treatment: A systematic review and meta-analysis

Jangipour Afshar P., Salehinejad S., and Shahesmaeili A.

Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 33 - 39)

Overdose Risk and Attitudes to Take-Home Naloxone Among Opioid Users in Prague and London: A Survey Comparison

Sefranek M., McDonald R., Kelleher M., Breidahl S., Pavlidis P., Miovsky M., and Strang J.

Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 41 - 50)

Different formulations of methadone and levomethadone in the management of Opioid Use Disorder.

Somaini L., Vecchio S., Salvatore D.F., Ercolini A., and Leonardi C.

Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 51 - 57)

Buprenorphine for opioid withdrawal syndrome management: comparison of different dose tapering protocols

Stella L., D'Ambra C., Di Donato L., Infantino R., Boccella S., Mirto B.F., Luongo L., Miele M., Pieretti G., Maione S., and Guida F.

Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 59 - 64)

Convergent validity of five-dimension psychopathology of Addiction: Relationships with Tridimensional Personality Questionnaire

Maremmani A.G.I., Della Rocca F., Bacciardi S., Miccoli M., and Maremmani I.

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page